Condition: Pancreatic Cancer · Sponsor: Herlev Hospital
EUS-FNB samples will be used for organoid cultures, which will be co-cultured with cancer associated fibroblasts derived from the surrounding stroma of the lesion. The organoid cultures will be used for pharmacotyping using relevant chemotherapeutic agents used in the clinic, and the organoid's response compared with the patient's response.
This description comes directly from the study's public registry record.
Pia H Klausen, PhD · +4535453545 · pia.helene.klausen.01@regionh.dk
Simon E Grutzmeier, MD · +4538683868 · simon.eban.grutzmeier@regionh.dk
Always discuss trial participation with your own doctor first.
| Endoscopy Unit, Herlev Hospital | Herlev, Copenhagen, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05196334